An Open-Labeled Pilot Study of Biomarker Response Following Short-Term Exposure to Metformin

NCT01816659 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

3

Enrollment

OTHER

Sponsor class

Stopped Slow Accrual

Conditions

Colorectal Carcinoma

Interventions

DRUG: Metformin ER

Sponsor

M.D. Anderson Cancer Center